Literature DB >> 10629118

Nuclear structural proteins as biomarkers of cancer.

B R Konety1, R H Getzenberg.   

Abstract

The regulation of cell processes is integrally connected to cellular and extracellular structure. Studies over the past three decades have demonstrated the complex interactions of cell structure and function. The relationship of cellular structure and function has perhaps been most studied in the transformed cell. The hallmark of transformation is alterations in the shape of the cell and the nucleus. Many of the cellular alterations observed in the cancer process are structural, including changes in extracellular matrix-cytoskeletal interactions, cytoskeletal elements, as well as nuclear structure. This review focuses on the structural components of the nucleus, the nuclear matrix, and their role in the cancer process and the use of these structural components of the nucleus, the nuclear matrix, and their role in the cancer process and the use of these structural components as cancer specific biomarkers. J. Cell. Biochem. Suppls. 32/33:183-191, 1999. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10629118     DOI: 10.1002/(sici)1097-4644(1999)75:32+<183::aid-jcb22>3.3.co;2-1

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  12 in total

Review 1.  An architectural genetic and epigenetic perspective.

Authors:  Gary S Stein; Janet L Stein; Andre J van Wijnen; Jane B Lian; Sayyed K Zaidi; Jeffrey A Nickerson; Martin A Montecino; Daniel W Young
Journal:  Integr Biol (Camb)       Date:  2010-12-24       Impact factor: 2.192

2.  Optical detection of the structural properties of tumor tissue generated by xenografting of drug-sensitive and drug-resistant cancer cells using partial wave spectroscopy (PWS).

Authors:  Prakash Adhikari; Prashanth K B Nagesh; Fatemah Alharthi; Subhash C Chauhan; Meena Jaggi; Murali M Yallapu; Prabhakar Pradhan
Journal:  Biomed Opt Express       Date:  2019-11-21       Impact factor: 3.732

3.  Nanoscale nuclear architecture for cancer diagnosis beyond pathology via spatial-domain low-coherence quantitative phase microscopy.

Authors:  Pin Wang; Rajan K Bista; Walid E Khalbuss; Wei Qiu; Shikhar Uttam; Kevin Staton; Lin Zhang; Teresa A Brentnall; Randall E Brand; Yang Liu
Journal:  J Biomed Opt       Date:  2010 Nov-Dec       Impact factor: 3.170

4.  Potential of soluble CD26 as a serum marker for colorectal cancer detection.

Authors:  Oscar J Cordero; Monica Imbernon; Loretta De Chiara; Vicenta S Martinez-Zorzano; Daniel Ayude; Maria Paez de la Cadena; F Javier Rodriguez-Berrocal
Journal:  World J Clin Oncol       Date:  2011-06-10

Review 5.  Mechanical regulation of nuclear structure and function.

Authors:  Rui P Martins; John D Finan; Farshid Guilak; David A Lee
Journal:  Annu Rev Biomed Eng       Date:  2012-05-22       Impact factor: 9.590

Review 6.  The three-dimensional organization of the genome in cellular senescence and age-associated diseases.

Authors:  Shane A Evans; Jeremy Horrell; Nicola Neretti
Journal:  Semin Cell Dev Biol       Date:  2018-07-27       Impact factor: 7.727

Review 7.  Nuclear structure as a source of cancer specific biomarkers.

Authors:  Eddy S Leman; Robert H Getzenberg
Journal:  J Cell Biochem       Date:  2008-08-15       Impact factor: 4.429

8.  Evaluation of colon cancer-specific antigen 2 as a potential serum marker for colorectal cancer.

Authors:  Eddy S Leman; Robert E Schoen; Ahmed Magheli; Lori J Sokoll; Daniel W Chan; Robert H Getzenberg
Journal:  Clin Cancer Res       Date:  2008-03-01       Impact factor: 12.531

9.  Analysis of a serum test for prostate cancer that detects a second epitope of EPCA-2.

Authors:  Eddy S Leman; Ahmed Magheli; Grant W Cannon; Leslie Mangold; Alan W Partin; Robert H Getzenberg
Journal:  Prostate       Date:  2009-08-01       Impact factor: 4.104

10.  Pathogenic and Diagnostic Potential of BLCA-1 and BLCA-4 Nuclear Proteins in Urothelial Cell Carcinoma of Human Bladder.

Authors:  Matteo Santoni; Francesco Catanzariti; Daniele Minardi; Luciano Burattini; Massimo Nabissi; Giovanni Muzzonigro; Stefano Cascinu; Giorgio Santoni
Journal:  Adv Urol       Date:  2012-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.